Atrial fibrillation (AFib) is a common heart arrhythmia that affects millions of people worldwide. It is characterized by an irregular and often rapid heart rate, which can lead to various symptoms, including shortness of breath, fatigue, palpitations, and chest pain.
The International Classification of Diseases, Tenth Revision (ICD-10) provides a standardized system for coding diseases and health conditions. For atrial fibrillation, the following ICD-10 codes are used:
ICD-10 Code | Description |
---|---|
I48.0 | Fibrillation and flutter of atria |
I48.1 | Paroxysmal atrial fibrillation |
I48.2 | Persistent atrial fibrillation |
I48.3 | Long-standing persistent atrial fibrillation |
I48.4 | Permanent atrial fibrillation |
I48.9 | Atrial fibrillation, unspecified |
In addition to these specific codes, AFib can also be coded using more general codes, such as:
ICD-10 Code | Description |
---|---|
I48 | Arrhythmias and conduction disturbances of atria |
I48.9 | Arrhythmias and conduction disturbances of atria, unspecified |
AFib is a common condition, with an estimated prevalence of over 33 million people worldwide. The prevalence of AFib increases with age, with over 10% of people over the age of 80 experiencing the condition.
AFib can have a significant impact on quality of life, leading to symptoms such as:
The following risk factors increase the likelihood of developing atrial fibrillation:
AFib is diagnosed through a physical examination and medical history, along with diagnostic tests such as:
The treatment of atrial fibrillation depends on the severity of the condition and the patient's individual needs. Treatment options include:
In addition to treatment, managing atrial fibrillation involves:
Atrial fibrillation is a common heart arrhythmia that can have a significant impact on quality of life. Accurate diagnosis and appropriate management are essential to reduce the risk of complications and improve outcomes. Healthcare professionals should be familiar with the ICD-10 codes for atrial fibrillation and the latest guidelines for its diagnosis and treatment.
Age Group | Prevalence |
---|---|
<65 | 0.5% |
65-74 | 3.5% |
75-84 | 8.8% |
85+ | 14.2% |
Source: European Heart Journal (2020)
Risk Factor | Relative Risk |
---|---|
Age (over 65) | 6.4 |
High blood pressure | 2.2 |
Heart disease | 1.9 |
Obesity | 1.8 |
Diabetes | 1.5 |
Sleep apnea | 1.4 |
Alcohol abuse | 1.3 |
Thyroid disease | 1.2 |
Source: Circulation (2019)
Symptom | Prevalence |
---|---|
Shortness of breath | 50-60% |
Fatigue | 40-50% |
Palpitations | 30-40% |
Chest pain | 20-30% |
Dizziness | 10-20% |
Confusion | 5-10% |
Source: Mayo Clinic (2023)
Treatment | Description |
---|---|
Medications | Antiarrhythmic drugs, rate control drugs, anticoagulants |
Electrical cardioversion | Procedure to restore normal heart rhythm |
Catheter ablation | Procedure to destroy abnormal electrical pathways in the heart |
Pacemaker or ICD therapy | Devices to regulate heart rate and rhythm |
Source: American Heart Association (2023)
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-12-25 08:37:27 UTC
2024-12-11 06:06:34 UTC
2024-12-26 08:16:14 UTC
2024-09-25 20:01:20 UTC
2024-09-25 20:01:35 UTC
2024-09-26 19:30:07 UTC
2024-09-28 01:35:05 UTC
2025-01-04 06:15:36 UTC
2025-01-04 06:15:36 UTC
2025-01-04 06:15:36 UTC
2025-01-04 06:15:32 UTC
2025-01-04 06:15:32 UTC
2025-01-04 06:15:31 UTC
2025-01-04 06:15:28 UTC
2025-01-04 06:15:28 UTC